Molds - Mold Mix 4
Generic Name: molds - mold mix 4
Brand Names:
Molds - Mold Mix 4
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ALTERNARIA ALTERNATA (.1 g/mL); ASPERGILLUS FUMIGATUS (.025 g/mL); ASPERGILLUS NIDULANS (.025 g/mL); ASPERGILLUS NIGER VAR. NIGER (.025 g/mL); ASPERGILLUS TERREUS (.025 g/mL); CLADOSPORIUM CLADOSPORIOIDES (.1 g/mL); CLONOSTACHYS ROSEA F. ROSEA (.025 g/mL); PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (.025 g/mL); PENICILLIUM DIGITATUM (.025 g/mL); PENICILLIUM EXPANSUM (.05 g/mL). Category: BLA.
Overview
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ALTERNARIA ALTERNATA (.1 g/mL); ASPERGILLUS FUMIGATUS (.025 g/mL); ASPERGILLUS NIDULANS (.025 g/mL); ASPERGILLUS NIGER VAR. NIGER (.025 g/mL); ASPERGILLUS TERREUS (.025 g/mL); CLADOSPORIUM CLADOSPORIOIDES (.1 g/mL); CLONOSTACHYS ROSEA F. ROSEA (.025 g/mL); PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (.025 g/mL); PENICILLIUM DIGITATUM (.025 g/mL); PENICILLIUM EXPANSUM (.05 g/mL). Category: BLA.
Dosage
Available as injection, solution for percutaneous use.
Related Medications
Dolichos Pruriens
dolichos pruriens
Adenosinum Ciclophosphoricum - Lilium Tigrinum - Melatonin - Sus Scrofa Adrenal Gland - Sus Scrofa Corpus Luteum - Sus Scrofa Hypothalamus - Sus Scrofa Ovary - Sus Scrofa Pancreas - Sus Scrofa Pineal Gland - Sus Scrofa Pituitary Gland - Sus Scrofa Thymus - Thyroid -
adenosinum ciclophosphoricum - lilium tigrinum - melatonin - sus scrofa adrenal gland - sus scrofa corpus luteum - sus scrofa hypothalamus - sus scrofa ovary - sus scrofa pancreas - sus scrofa pineal gland - sus scrofa pituitary gland - sus scrofa thymus - thyroid -
USES Temporary relief of symptoms due to menstrual irregularities or hormonal imbalances, such as: Mood Fluctuations Irritability Sleep disturbance
Allogenic Thymocyte-depleted Thymus Tissue-agdc
allogenic thymocyte-depleted thymus tissue-agdc
11 DESCRIPTION RETHYMIC consists of yellow to brown slices of allogeneic processed thymus tissue for administration by surgical implantation. Three to 11 drug product containers, with a total of 10 to 42 RETHYMIC slices, are provided for each patient. Each drug product container provides up to 4 RETHYMIC slices of variable size. The total dose, based on the number of slices administered to the patient, is 5,000 to 22,000 mm 2 of RETHYMIC/m 2 recipient BSA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.